ECB to Be ‘Pragmatic' in Policing Banks' Carbon Transition Plans
The ECB will take a gradual, 'pragmatic and targeted approach' to such transition planning when a relevant requirement takes effect next year, Executive Board Member Frank Elderson wrote in a blog post on Friday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Sky Sports Journalist: ‘Liverpool remain a concrete option' for €100m Striker
Liverpool Monitor Frankfurt Striker as Transfer Market Heats Up Eintracht Frankfurt face a crucial summer as they prepare for Champions League football. While securing top-four Bundesliga status was a significant achievement, attention has quickly turned to the future of their 23-year-old striker, who is drawing interest from several Premier League clubs — most notably Liverpool. Advertisement Although no formal negotiations have taken place, there's growing anticipation around an official approach. Frankfurt are believed to be open to a sale if the price is right, with a valuation of around €100m being discussed internally. The striker, who joined Frankfurt from Paris Saint-Germain, finished the season in strong form. His performances have not gone unnoticed, and his availability has prompted renewed interest from English sides looking to bolster their attacking options. Liverpool's Interest Reflects Strategic Forward Planning Liverpool's interest in the Frankfurt forward is not unexpected. The Merseyside club have been actively monitoring talent that fits their evolving tactical blueprint under Arne Slot. With age on his side, this particular target represents a blend of athleticism, technical potential and the ability to play across the front line — a profile that Liverpool are known to value highly. Advertisement As the club reshapes its forward line, the 23-year-old presents an appealing option, especially given the uncertainty surrounding the futures of several current squad members. While no formal offer has been made, sources suggest Liverpool could escalate their interest in the coming weeks should Frankfurt's stance soften. Other Premier League Clubs Maintain Strong Interest While Liverpool remain firmly in the conversation, they're not alone. Newcastle United have revived their pursuit of the Frankfurt attacker, and Manchester United are also keeping tabs on developments. Chelsea, by contrast, are understood to be out of the running following their recent acquisition of Joao Pedro. Advertisement The player's €100m price tag could complicate matters, particularly given Financial Fair Play considerations. However, Frankfurt are bracing for bids and understand that a major sale this summer may be inevitable — particularly if the offers align with their internal valuation. Frankfurt's Champions League Plans May Hinge on Key Sale From Frankfurt's perspective, retaining their top scorer would be ideal as they prepare for European competition. Club officials are keen to build around a young, dynamic squad, but financial realities may dictate their summer strategy. According to reports, the Bundesliga side 'would like to keep him, also to be well prepared for the Champions League,' but are aware that 'offers are expected this month.' Should a suitable proposal arrive — particularly from one of England's elite — Frankfurt will face a significant decision. Advertisement While Liverpool have yet to make their move, their interest underlines the growing appeal of this emerging Bundesliga star. Whether he moves to Anfield or elsewhere remains to be seen, but what's certain is that Frankfurt's No. 9 is firmly on the radar across the Premier League.
Yahoo
an hour ago
- Yahoo
Aegis Capital Reaffirms Buy on Atai Life Sciences N.V. (ATAI) with $8 Target
Atai Life Sciences N.V. (NASDAQ:ATAI) is among the . Aegis Capital analysts have reaffirmed their Buy rating on Atai Life Sciences N.V. (NASDAQ:ATAI), with an unchanged price target of $8.00, following the favorable Phase 2b results of the BPL-003 treatment for the company's Treatment Resistant Depression (TRD). Around 193 depression patients, who didn't respond to previous treatment, were part of the Phase 2b trial testing three doses: 0.3 mg, 8 mg, and 12 mg. Not only the 8mg but also the 12mg dose showcased statistically significant improvement in an FDA-accepted measurement of depression, with a healthy side-effect profile. A close-up of a medical professional providing advice to a patient struggling with opioid use disorder. The research firm believes these robust results strengthen the company's efforts to proceed to a Phase 3 clinical program, which would result in marketing approval. Going forward, Atai Life Sciences N.V. (NASDAQ:ATAI) plans to schedule a post-Phase 2 meeting with the FDA, with the Phase 3 trial expected to begin only at the end of the upcoming year. Another noteworthy development is the company's recent $50 million private capital raise, which involved the sale of 18,264,840 common shares with 25% warrant coverage at the market price. Moves like these highlight Atai Life Sciences N.V. (NASDAQ:ATAI)'s capacity to raise cash when needed. Atai Life Sciences N.V. (NASDAQ:ATAI) is a German clinical-stage biopharmaceutical company that researches, develops, and markets mental health treatments in the United States, Germany, and Canada. With a market capitalization of $587.639 million, the company is committed to healing mental health disorders. While we acknowledge the potential of ATAI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Bloomberg
an hour ago
- Bloomberg
Labour Fails to Boost UK Living Standards After One Year on Job
UK living standards are no higher than when Labour swept to power a year ago, highlighting the problems piling up for Prime Minister Keir Starmer as he struggles to contain the rise of Nigel Farage's populist Reform UK party. Discretionary incomes tumbled 4.2% in April after a wave of bill increases and tax hikes, and failed to improve in May — the worst two months for households since the spring of 2022 when Russia's invasion of Ukraine sent energy prices rocketing, according to Retail Economics. In total, they have fallen 7.5% this year to levels seen just after Labour won a landslide victory in July last year, with the least well off hit hardest.
